RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 79 filers reported holding RAYTHEON CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $2,278,000 | -54.9% | 17,370 | -24.5% | 0.19% | -42.6% |
Q4 2019 | $5,054,000 | +13.0% | 22,999 | +0.9% | 0.34% | +5.0% |
Q3 2019 | $4,471,000 | +12.8% | 22,789 | 0.0% | 0.32% | +8.4% |
Q2 2019 | $3,963,000 | -3.5% | 22,789 | +1.1% | 0.30% | -7.5% |
Q1 2019 | $4,106,000 | +4.1% | 22,550 | -12.4% | 0.32% | -11.3% |
Q4 2018 | $3,946,000 | -50.5% | 25,735 | -33.2% | 0.36% | -42.4% |
Q3 2018 | $7,965,000 | +7.1% | 38,540 | +0.1% | 0.63% | -1.3% |
Q2 2018 | $7,440,000 | -9.3% | 38,515 | +1.3% | 0.64% | -11.4% |
Q1 2018 | $8,203,000 | +19.6% | 38,010 | +4.2% | 0.72% | +19.7% |
Q4 2017 | $6,856,000 | +5.5% | 36,495 | +4.8% | 0.60% | +1.7% |
Q3 2017 | $6,499,000 | +34.0% | 34,830 | +16.0% | 0.59% | +27.4% |
Q2 2017 | $4,849,000 | +166.7% | 30,030 | +151.9% | 0.46% | +153.0% |
Q1 2017 | $1,818,000 | +10.4% | 11,920 | +2.8% | 0.18% | +4.6% |
Q4 2016 | $1,647,000 | +9.1% | 11,600 | +4.6% | 0.18% | +4.2% |
Q3 2016 | $1,510,000 | +0.7% | 11,095 | +0.6% | 0.17% | +1.8% |
Q2 2016 | $1,499,000 | +14.4% | 11,025 | +3.2% | 0.16% | +8.6% |
Q1 2016 | $1,310,000 | +0.8% | 10,680 | +2.3% | 0.15% | -6.7% |
Q4 2015 | $1,300,000 | +11718.2% | 10,440 | +10340.0% | 0.16% | +16200.0% |
Q3 2015 | $11,000 | +10.0% | 100 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $10,000 | -75.6% | 100 | -73.3% | 0.00% | -80.0% |
Q1 2015 | $41,000 | 0.0% | 375 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $41,000 | +7.9% | 375 | 0.0% | 0.01% | -16.7% |
Q3 2014 | $38,000 | +8.6% | 375 | 0.0% | 0.01% | +20.0% |
Q2 2014 | $35,000 | – | 375 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |